| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia
|
Lasica, Masa
|
|
|
35 |
4 |
p. 761-773
|
artikel
|
| 2 |
Can Immunocompetence Be Restored in Chronic Lymphocytic Leukemia?
|
Sun, Clare
|
|
|
35 |
4 |
p. 827-845
|
artikel
|
| 3 |
Chronic Lymphocytic Leukemia
|
Brown, Jennifer R.
|
|
|
35 |
4 |
p. i
|
artikel
|
| 4 |
Chronic Lymphocytic Leukemia: So Much Progress, Still Challenges Ahead
|
Brown, Jennifer R.
|
|
|
35 |
4 |
p. xiii-xiv
|
artikel
|
| 5 |
Contents
|
|
|
|
35 |
4 |
p. vii-x
|
artikel
|
| 6 |
Contributors
|
|
|
|
35 |
4 |
p. iii-v
|
artikel
|
| 7 |
Copyright
|
|
|
|
35 |
4 |
p. ii
|
artikel
|
| 8 |
First-Line Therapy for Chronic Lymphocytic Leukemia
|
Cherng, Hua-Jay J.
|
|
|
35 |
4 |
p. 725-738
|
artikel
|
| 9 |
Forthcoming Issues
|
|
|
|
35 |
4 |
p. xi
|
artikel
|
| 10 |
Genomics of Resistance to Targeted Therapies
|
Thangavadivel, Shanmugapriya
|
|
|
35 |
4 |
p. 715-724
|
artikel
|
| 11 |
Immune Therapy for Chronic Lymphocytic Leukemia
|
Shadman, Mazyar
|
|
|
35 |
4 |
p. 847-862
|
artikel
|
| 12 |
Potential Relevance of B-cell Maturation Pathways in Defining the Cell(s) of Origin for Chronic Lymphocytic Leukemia
|
Ng, Anita
|
|
|
35 |
4 |
p. 665-685
|
artikel
|
| 13 |
Prognostic and Predictive Implications of Cytogenetics and Genomics
|
Ljungström, Viktor
|
|
|
35 |
4 |
p. 703-713
|
artikel
|
| 14 |
Should Undetectable Minimal Residual Disease Be the Goal of Chronic Lymphocytic Leukemia Therapy?
|
Al-Sawaf, Othman
|
|
|
35 |
4 |
p. 775-791
|
artikel
|
| 15 |
The Evolving Use of Phosphatidylinositol 3-Kinase Inhibitors for the Treatment of Chronic Lymphocytic Leukemia
|
Lampson, Benjamin L.
|
|
|
35 |
4 |
p. 807-826
|
artikel
|
| 16 |
The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia
|
Ding, Wei
|
|
|
35 |
4 |
p. 739-759
|
artikel
|
| 17 |
The Significance of B-cell Receptor Stereotypy in Chronic Lymphocytic Leukemia
|
Vlachonikola, Elisavet
|
|
|
35 |
4 |
p. 687-702
|
artikel
|
| 18 |
Treatment of Chronic Lymphocytic Leukemia After Discontinuation of Bruton’s Tyrosine Kinase Inhibitors
|
Thompson, Meghan C.
|
|
|
35 |
4 |
p. 793-806
|
artikel
|
Tijdschrift beschrijving